Skip to main content
Database: The Journal of Biological Databases and Curation logoLink to Database: The Journal of Biological Databases and Curation
. 2026 Jul 31;2026:baag045. doi: 10.1093/database/baag045

The Asparaginase Database: a comprehensive resource and classification of l-asparaginases

Max Štětina 1, Aleš Křenek 2, Guglielmo Tedeschi 3, Filip Krása 4, Vojtěch Spiwok 5, Eva Benešová 6,✉
PMCID: PMC13425635  PMID: 42535890

Abstract

l-Asparaginases have been essential anticancer biopharmaceuticals for nearly half a century, particularly in the treatment of acute lymphoblastic leukaemia. Despite their success, current preparations face challenges, such as strong immunogenicity, reduced stability, and secondary l-glutaminase activity. Systematic discovery and engineering of l-asparaginases with desirable properties are hindered by the limitations of existing l-asparaginase classifications being unable to keep pace with rapid sequence discovery or not reflecting the growing diversity of l-asparaginase characteristics. We present The Asparaginase Database, a resource for curated l-asparaginase sequences, conserved motifs, structures, and experimental data organised by a sequence similarity driven classification into 40 phylogenetic families and 14 clans within previously established l-asparaginase classes. This framework provides a new model for the classification of l-asparaginases based on large-scale molecular phylogeny and could enable researchers to navigate l-asparaginase diversity and identify promising candidates for therapeutic development. Database URL:  https://asparaginasedb.com/

Introduction

l-Asparaginases are a group of enzymes that catalyse the hydrolysis of l-asparagine to l-aspartate and ammonium. This reaction is important in nitrogen metabolism and maintaining cellular and physiological homeostasis [1]. l-Asparaginases are found in all domains of life, and sequences are commonly present in several isoforms. Consequently, they emerge as a highly diverse group, characterised by diverse quaternary structures and distinct amino acid sequences, while sometimes accepting various substrates beyond l-asparagine [1,2].

l-Asparaginases (EC 3.5.1.1) have become an integral part of chemotherapeutic regimens for paediatric patients with haematological malignancies, particularly acute lymphoblastic leukaemia. These malignant cells lack the ability to adequately synthesise l-asparagine de novo and depend on extracellular sources [3]. Survival rates of children with acute lymphoblastic leukaemia rose from 10% to 90% following decades of improvements in multi-agent therapeutic regimens [4], which include l-asparaginase. Furthermore, l-asparaginase therapies could have potential in the treatment of some solid tumours [5].

However, many patients suffer from severe side effects, such as hepatotoxicity, pancreatitis, thrombosis, and allergic reactions [6]. Therefore, the development of l-asparaginases with reduced immunogenicity, improved stability, and high affinity and specificity for l-asparagine remains crucial for minimising toxicity in treatments. As clinically approved l-asparaginases are of bacterial origin (Escherichia coli and Dickeya dadantii), exploring enzymes from alternative sources may offer distinct therapeutic advantages, both to improve current treatments and to expand into other applications where tolerability issues have limited their clinical exploration [7].

Another important application of l-asparaginases is in the food industry, where they are used to lower acrylamide levels in carbohydrate-rich heat-processed foods such as fried potato products and bakery products [8]. The neurotoxic effects of acrylamide are well-studied [9] and it is classified as a probable carcinogen [10]. The hydrolysis of l-asparagine prevents it from reacting with reducing sugars at high temperatures and creating acrylamide in the process known as the Maillard reaction. Ongoing research is focused on developing improved or characterising novel l-asparaginases with properties tailored for safer food processing and biosensors [11]. This research gains additional relevance as the European Union has been working towards legally binding maximum levels for acrylamide (European Commission, ‘Acrylamide’, https://food.ec.europa.eu/food-safety/chemical-safety/contaminants/catalogue/acrylamide_en, accessed 20 June 2026).

Classification is central to understanding, discovering, and developing l-asparaginases. Historically, these enzymes have been divided into three families: bacterial-type, plant-type, and Rhizobium etli-type [12], named after representative members of each group. This nomenclature can be a source of confusion, as the sequences in each family commonly originate from organisms across multiple domains. The bacterial-type family was further subdivided into type I (cytoplasmic) and type II (periplasmic) l-asparaginases. This subdivision stems from the early characterisation of l-asparaginase isoforms from E. coli, which served as the model system [13].

To update this, da Silva et al. [2] proposed a new classification based on peptide domains, phylogenetic data, structural analysis, and functional characteristics. Their system defines three classes that parallel the historical families but avoids taxonomic labels: Class 1 (formerly bacterial-type), Class 2 (plant-type), and Class 3 (R. etli-type). Classes 1 and 2 are subdivided into four and three groups, respectively, organised according to distinct features. However, the phylogenetic analysis was performed on 337 manually selected sequences, while sequence homology searches identify over 100 000 unique putative l-asparaginases.

Following this, Loch and Jaskolski [1] proposed an alternative classification that expands on the historical model. They endorsed the detachment from biological taxonomy but argued against renaming historically established enzymes. While this system addresses the taxonomic nomenclature issue, it relies on a limited set of model enzymes that may not represent the full diversity of their respective families. Table 1 sets the two systems alongside each other for a selection of representative sequences.

Table 1.

Representative l-asparaginase and related sequences mapped to both the da Silva et al. [2] and Loch and Jaskolski [1] classification systems

da Silva et al. [2] Loch and Jaskolski [1]
UniProt ID Short name UniProt protein name Organism Class Group Typea Sub-type
P00805 EcAII l-asparaginase 2 Escherichia coli Class 1 Group 1 bacterial type 2
P38986 ScAIb l-asparaginase 1 Saccharomyces cerevisiae Group 2
Q9V0T9 – Glutamyl-tRNAGln amidotransferase subunit D Pyrococcus abyssi Group 3 type 1
P0A962 EcAI l-asparaginase 1 Escherichia coli Group 4
P37595 EcAIII Isoaspartyl peptidase Escherichia coli Class 2 Group 1 plant type 3
Q9H6P5 – Threonine aspartase 1 Homo sapiens Group 2
P20933 – N(4)-(β-N-acetylglucosaminyl)-l-asparaginase Homo sapiens Group 3
Q2KB35 ReAIV l-asparaginase IIc protein Rhizobium etli Class 3 – R. etli type 4
Q2K0Z2 ReAV l-asparaginase IIc protein Rhizobium etli type 5

Sequences not explicitly classified by Loch and Jaskolski [1] were assigned based on sequence similarity to those that were classified.

aAlthough Loch and Jaskolski [1] adopted the class nomenclature, this table contains the historical types for context.

bThe S. cerevisiae ScAI (P38986) was sometimes considered a type 1 (or type I) l-asparaginase; however, the sequence is more similar to type 2 l-asparaginases.

cThe protein name l-asparaginase II is unrelated to the type 2 (or type II) classification of l-asparaginases.

These limitations motivated the development of a classification system based on comprehensive sequence analyses: scalable, unbiased, and encompassing all known l-asparaginase and l-asparaginase-like sequences identified by homology alongside characterised enzymes. To this end, we developed an l-asparaginase database that integrates sequences, structures, and experimental data within the comprehensive classification.

Materials and methods

The UniRef100 database (Release 2023_03) [14] was selected as the primary sequence source for the bioinformatic analysis underlying the classification due to its comprehensive coverage and non-redundancy. The well-annotated sequences from Swiss-Prot (Release 2023_02) [15] served as reference points for the classification.

The Protein Data Bank (PDB) [16] was accessed through the European Bioinformatics Institute website on 17 October 2023 and subsequently monitored for l-asparaginases with experimentally determined structures. Structures in the AlphaFold Protein Structure Database [17,18] were analysed when experimentally solved structures were not available. Structures were further identified and compared with Foldseek release 10 [19].

The literature was systematically searched for experimentally characterised enzymes whose biochemical data could be linked to a specific sequence.

To identify l-asparaginase sequences for analysis, the Swiss-Prot and UniRef100 databases were searched for l-asparaginases with BLASTP version 2.10.0+ [20]. The default settings were used, except the E-value, which was set to 10–3 for the Swiss-Prot search and to 10–4 for the UniRef100 search and used as the defining cut-off. Query sequences were selected from each group in the da Silva et al. [2] classification, providing the basis for broader similarity-based discovery. The selected query sequences, categorised according to previous classifications, are listed in Table 1 (except ReAIV, which was omitted as a query sequence due to near-complete redundancy with ReAV in Class 3). BLAST results from queries within each class were combined separately for each database, and duplicate sequences resulting from multiple queries per class were removed. No sequence overlap was observed between classes.

Sequences retrieved from UniRef100 were clustered using CD-HIT version 4.8.1 [21] at 80% sequence identity; other parameters remained at default settings. Next, Swiss-Prot and clustered UniRef100 representatives were pooled. Although UniRef100 incorporates Swiss-Prot sequences, clustering at 80% identity often selected non-Swiss-Prot sequences as cluster representatives, necessitating manual readdition of Swiss-Prot sequences to preserve well-annotated reference points in the alignment. Alignments were generated with Fast and Accurate Multiple Sequence Alignment (FAMSA) version 2.2.2 [22] with default settings. Approximate maximum-likelihood phylogenetic trees were inferred using FastTree version 2.1.11 [23] with default settings for protein sequences.

After individual phylogenetic trees were constructed for each class, Swiss-Prot sequences, solved structures, and experimentally studied proteins were mapped onto the trees. Branch lengths and local support values were analysed in iTOL v6 [24] to define initial family boundaries. Each putative family was taxonomically profiled using UniProt ID mapping. Sequences within each initial family were clustered at 70% sequence identity using CD-HIT with otherwise default settings, and 100 sequences were randomly sampled. These subsets were aligned using Clustal Omega version 1.2.4 [25] with default parameters, and alignments were stripped of sequences exhibiting likely sequencing errors and rendered in Jalview version 2.11.5.1 [26]. The conserved sequence motifs were identified and mapped onto representative sequences from each family. The family boundaries were iteratively refined (if necessary), with additional consideration given to oligomeric organisation, structural features, taxonomic origin, and catalytic function when such data were available. Finally, phylogenetically related families were grouped into clans.

The Asparaginase Database (https://asparaginasedb.com/) is deployed on a Kubernetes infrastructure running on Linux. Sequence similarity searches (NCBI BLASTP version 2.12.0+) are executed with a Python FastAPI backend, enabling users to search separately in the full database, experimentally studied proteins, and Swiss-Prot entries. Website development was assisted by Claude from Anthropic. The infrastructure includes maintenance and update capabilities to ensure data consistency across the hierarchical classification system. We plan to semi-automatically update the database twice a year. Its maintenance is supported by ELIXIR Czech Republic.

Results and discussion

The database covers a manually curated set of 101 experimentally studied proteins from the literature (including 32 with solved structures), 127 manually curated sequences from Swiss-Prot, and 126 085 classified sequences from UniRef100. The database contains not only l-asparaginases, but also evolutionarily related enzymes such as mixed l-asparaginases/l-glutaminases, β-aspartyl-peptidases, Glu-tRNAGln amidotransferases, aspartyl-glucosaminidases, and others. Users can browse entries with kinetic and structural data, search and filter the database by various parameters, classify sequences or identify the closest experimentally characterised proteins using BLAST, download organised data and sequences, and access linked source publications.

The enzymes are classified into three classes previously established in the literature, now further divided into 14 clans consisting of 40 phylogenetic families (Fig. 1). This hierarchical structure is analogous to the CAZy database [27] for carbohydrate-active enzymes, which classifies enzymes on the basis of sequence and structure rather than substrate specificity. Detailed class and family pages contain additional information (e.g. taxonomic origin, substrate specificity), phylogenetic trees, representative sequence alignments, and conserved motifs.

Figure 1.

Six-panel Fig. showing ribbon structures and phylogenetic trees for the three classes of asparaginases, with 18, 18, and 4 numbered phylogenetic families respectively.

Illustrative structures from the front page of the database pointing to classes 1, 2, and 3 with the corresponding phylogenetic trees; numbers indicate the phylogenetic families within each class.

As the classification is based on molecular phylogeny, it is more objective and scalable. While the previous phylogenetic classification by da Silva et al. [2] examined 337 manually selected sequences, our classification is by far the most comprehensive to date. This integration of classification and online database also allows users to easily determine the class, clan, and family assignment of any analysed sequence, as well as novel sequences with similarity searches.

Within this classification, many families consist almost exclusively of enzymes originating from a single taxonomic group, while others are taxonomically diverse, likely due to horizontal gene transfer events. Other trends, such as thermal stability, high affinity for l-asparagine, or presence of additional domains, can be observed but are not always correlated with individual families, reflecting the complex evolutionary history of these enzymes.

The classification avoids historical nomenclature issues, while the database provides historically assigned protein names for context. Most phylogenetic families are precisely defined by evolutionary distance and local support values, supplemented by experimental, structural, and taxonomic context, although a few remain weakly supported, and some sequence placements within these should be considered tentative. Unlike the manually curated entries, sequences from UniRef100 were not filtered before inclusion and may contain sequencing errors or represent non-functional proteins; we recommend comparing sequences to the alignments and conserved motifs of the relevant families before further use. Many families also lack experimentally studied representatives, presenting opportunities for characterising enzymes that may exhibit novel properties or contain previously unreported l-asparaginase conserved motifs. Not all characterised l-asparaginases in the literature are included, often due to publications lacking sufficient data for inclusion or classification of the sequence.

Conclusion

The Asparaginase Database is the first dedicated resource for l-asparaginases and related proteins organised by large-scale phylogenetic classification, enabling researchers to search, classify, and explore the sequence, structural, and kinetic landscape of these enzymes.

Acknowledgements

The authors thank the COST Action CA21149 (ACRYRED).

Contributor Information

Max Štětina, Department of Biochemistry and Microbiology, University of Chemistry and Technology, Prague, Technická 3, Prague 6, 166 28, Czech Republic.

Aleš Křenek, Institute of Computer Science, Masaryk University, Šumavská 416/15, Brno, 602 00, Czech Republic.

Guglielmo Tedeschi, Department of Biochemistry and Microbiology, University of Chemistry and Technology, Prague, Technická 3, Prague 6, 166 28, Czech Republic.

Filip Krása, Institute of Computer Science, Masaryk University, Šumavská 416/15, Brno, 602 00, Czech Republic.

Vojtěch Spiwok, Department of Biochemistry and Microbiology, University of Chemistry and Technology, Prague, Technická 3, Prague 6, 166 28, Czech Republic.

Eva Benešová, Department of Biochemistry and Microbiology, University of Chemistry and Technology, Prague, Technická 3, Prague 6, 166 28, Czech Republic.

Author contributions

Conceptualisation: EB, VS; methodology: MŠ, GT, VS; software: MŠ, AK, FK, VS; formal analysis: MŠ; investigation: MŠ; data curation: MŠ; writing, original draft: MŠ; writing, review and editing (equal): MŠ, VS, EB; writing, review and editing (supporting): AK, GT, FK; supervision: EB, VS; project administration: EB; funding acquisition: GT, VS, EB; resources: AK, FK.

Conflicts of interest

The authors declare no conflicts of interest.

Funding

This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic [grant numbers LM2023055 (ELIXIR CZ), ID:90254 (E-INFRA), and A2 FPBT 2025 014 (Specific University Research)].

Data availability

The data underlying this article are available in The Asparaginase Database at https://asparaginasedb.com/, and are released under a CC BY 4.0 license.

References

  • 1. Loch  JI, Jaskolski  M. Structural and biophysical aspects of l-asparaginases: a growing family with amazing diversity. IUCrJ. 2021;8:514–31. 10.1107/S2052252521006011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. da Silva  LS, Doonan  LB, Pessoa  A Jr  et al.  Structural and functional diversity of asparaginases: overview and recommendations for a revised nomenclature. Biotechnol Appl Biochem. 2022;69:503–13. 10.1002/bab.2127 [DOI] [PubMed] [Google Scholar]
  • 3. Prager  MD, Bachynsky  N. Asparagine synthetase in normal and malignant tissues; correlation with tumor sensitivity to asparaginase. Arch Biochem Biophys. 1968;127:645–54. 10.1016/0003-9861(68)90273-7 [DOI] [PubMed] [Google Scholar]
  • 4. Hunger  SP, Mullighan  CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373:1541–52. 10.1056/NEJMra1400972 [DOI] [PubMed] [Google Scholar]
  • 5. Van Trimpont  M, Peeters  E, De Visser  Y  et al.  Novel insights on the use of l-asparaginase as an efficient and safe anti-cancer therapy. Cancers. 2022;14:902. 10.3390/cancers14040902 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Shrivastava  A, Khan  AA, Khurshid  M  et al.  Recent developments in l-asparaginase discovery and its potential as anticancer agent. Crit Rev Oncol Hematol. 2016;100:1–10. 10.1016/j.critrevonc.2015.01.002 [DOI] [PubMed] [Google Scholar]
  • 7. Hays  JL, Kim  G, Walker  A  et al.  A phase II clinical trial of polyethylene glycol-conjugated l-asparaginase in patients with advanced ovarian cancer: early closure for safety. Mol Clin Oncol. 2013;1:565–69. 10.3892/mco.2013.99 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Jia  R, Wan  X, Geng  X  et al.  Microbial l-asparaginase for application in acrylamide mitigation from food: current research status and future perspectives. Microorganisms. 2021;9:1659. 10.3390/microorganisms9081659 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Erkekoglu  P, Baydar  T. Acrylamide neurotoxicity. Nutr Neurosci. 2014;17:49–57. 10.1179/1476830513Y.0000000065 [DOI] [PubMed] [Google Scholar]
  • 10. IARC . Acrylamide. In: Some Industrial Chemicals. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 60. Lyon: IARC, 1994;389–433. [PMC free article] [PubMed] [Google Scholar]
  • 11. Thakur  M, Tiwari  SK, Bansal  S. l-Asparaginase: a review of microbial production and protein engineering with translational applications for oncology and food safety. World J Microbiol Biotechnol. 2025;41:389. 10.1007/s11274-025-04614-1 [DOI] [PubMed] [Google Scholar]
  • 12. Borek  D, Jaskolski  M. Sequence analysis of enzymes with asparaginase activity. Acta Biochim Pol. 2001;48:893–902. 10.18388/abp.2001_3855 [DOI] [PubMed] [Google Scholar]
  • 13. Lubkowski  J, Wlodawer  A. Structural and biochemical properties of l-asparaginase. FEBS J. 2021;288:4183–209. 10.1111/febs.16042 [DOI] [PubMed] [Google Scholar]
  • 14. Suzek  BE, Huang  H, McGarvey  P  et al.  UniRef: comprehensive and non-redundant UniProt reference clusters. Bioinformatics. 2007;23:1282–88. 10.1093/bioinformatics/btm098 [DOI] [PubMed] [Google Scholar]
  • 15. Bairoch  A, Apweiler  R. The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000. Nucleic Acids Res. 2000;28:45–48. 10.1093/nar/28.1.45 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. wwPDB  consortium. Protein Data Bank: the single global archive for 3D macromolecular structure data. Nucleic Acids Res. 2019;47:D520–28. 10.1093/nar/gky949 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Jumper  J, Evans  R, Pritzel  A  et al.  Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583–89. 10.1038/s41586-021-03819-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Fleming  J, Magana  P, Nair  S  et al.  AlphaFold Protein Structure Database and 3D-Beacons: new data and capabilities. J Mol Biol. 2025;437:168967. 10.1016/j.jmb.2025.168967 [DOI] [PubMed] [Google Scholar]
  • 19. van Kempen  M, Kim  SS, Tumescheit  C  et al.  Fast and accurate protein structure search with Foldseek. Nat Biotechnol. 2024;42:243–46. 10.1038/s41587-023-01773-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Altschul  SF, Madden  TL, Schäffer  AA  et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389–402. 10.1093/nar/25.17.3389 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Fu  L, Niu  B, Zhu  Z  et al.  CD-HIT: accelerated for clustering the next-generation sequencing data. Bioinformatics. 2012;28:3150–52. 10.1093/bioinformatics/bts565 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Deorowicz  S, Debudaj-Grabysz  A, Gudyś  A. FAMSA: fast and accurate multiple sequence alignment of huge protein families. Sci Rep. 2016;6:33964. 10.1038/srep33964 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Price  MN, Dehal  PS, Arkin  AP. FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol. 2009;26:1641–50. 10.1093/molbev/msp077 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Letunic  I, Bork  P. Interactive Tree of Life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool. Nucleic Acids Res. 2024;52:W78–82. 10.1093/nar/gkae268 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Sievers  F, Wilm  A, Dineen  D  et al.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 2011;7:539. 10.1038/msb.2011.75 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Waterhouse  AM, Procter  JB, Martin  DMA  et al.  Jalview Version 2—a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009;25:1189–91. 10.1093/bioinformatics/btp033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Drula  E, Garron  M-L, Dogan  S  et al.  The carbohydrate-active enzyme database: functions and literature. Nucleic Acids Res. 2022;50:D571–77. 10.1093/nar/gkab1045 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data underlying this article are available in The Asparaginase Database at https://asparaginasedb.com/, and are released under a CC BY 4.0 license.


Articles from Database: The Journal of Biological Databases and Curation are provided here courtesy of Oxford University Press

RESOURCES